 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Signature Genomics to Adopt Agilent Platform in Light of Roche's Planned Departure from Array Market
July 31, 2012
Signature Genomics to Adopt Agilent Platform in Light of Roche's Planned Departure from Array Market
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance
August 21, 2012 / BioArray News - Affymetrix to Start Clinical Trials for CytoScan HD in March, Plans FDA Submission by Midyear
January 17, 2012 / BioArray News - Consumer Genetics Sales, GWAS, BlueGnome Drive Illumina Q1 Microarray Revenue Growth
April 23, 2013 / BioArray News - Amid Market Exits and Acquisitions, 2012 Saw Arrays Gain Ground in Prenatal, DTC Markets
January 2, 2013 / BioArray News - Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
December 11, 2012 / BioArray News